SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-014682
Filing Date
2020-06-11
Accepted
2020-06-11 15:56:12
Documents
2
Period of Report
2020-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea122959-8k_immucell.htm 8-K 39986
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF IMMUCELL CORPORATION ea122959ex3-1_immucell.htm EX-3.1 4968
  Complete submission text file 0001213900-20-014682.txt   46141
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 20957106
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences